Chicago Capital LLC Has $17.84 Million Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Chicago Capital LLC lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 34,176 shares of the medical equipment provider’s stock after acquiring an additional 2,601 shares during the period. Chicago Capital LLC’s holdings in Intuitive Surgical were worth $17,839,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Berbice Capital Management LLC bought a new position in Intuitive Surgical in the fourth quarter worth $26,000. Godsey & Gibb Inc. lifted its position in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical in the third quarter worth $33,000. Decker Retirement Planning Inc. bought a new position in Intuitive Surgical in the fourth quarter worth $36,000. Finally, Capital Performance Advisors LLP bought a new position in Intuitive Surgical in the third quarter worth $38,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 1.4 %

Intuitive Surgical stock opened at $571.88 on Monday. The firm has a market capitalization of $203.69 billion, a P/E ratio of 89.22, a PEG ratio of 5.51 and a beta of 1.39. The business has a 50-day moving average of $550.40 and a 200-day moving average of $509.43. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of analyst reports. Piper Sandler reissued an “overweight” rating and set a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Bernstein Bank lifted their price target on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a report on Monday, January 27th. Wells Fargo & Company lifted their price target on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Evercore ISI lifted their price target on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Finally, BTIG Research lifted their price target on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the sale, the executive vice president now owns 5,506 shares in the company, valued at $2,967,734. This represents a 6.39 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, CFO Jamie Samath sold 94 shares of the company’s stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares in the company, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 28,843 shares of company stock worth $15,357,560. Corporate insiders own 0.80% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.